Profusa (PFSA) Other Non-Current Liabilities (2021 - 2026)
Profusa (PFSA) posted quarterly Other Non-Current Liabilities of $11.4 million for Q1 2026, up 33332.88% year-over-year from N/an in Q1 2025, and down 7.43% quarter-over-quarter from $12.3 million in Q4 2025.
Profusa (PFSA) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
Profusa's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $11.4 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 33332.88% year-over-year to $11.4 million; the TTM figure through Mar 2026 stood at $11.4 million (up 33332.88% YoY), while the FY2025 annual figure was $12.3 million, up 452.15% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $11.4 million, down from $12.3 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $18.8 million in Q3 2025, with the low at $31308.0 in Q2 2024.
- The 5-year median for Other Non-Current Liabilities is $652659.0 (2024), against an average of $4.2 million.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities slumped 98.55% in 2023, then soared 55616.4% in 2025.
- Profusa's Other Non-Current Liabilities stood at $407131.0 in 2022, then slumped by 83.76% to $66128.0 in 2023, then surged by 3278.3% to $2.2 million in 2024, then surged by 452.15% to $12.3 million in 2025, then decreased by 7.43% to $11.4 million in 2026.
- Business Quant data shows PFSA's Other Non-Current Liabilities at $11.4 million in Q1 2026, $12.3 million in Q4 2025, and $18.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Profusa | 92,085.85 | -282,914.15 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.42 Mn |
| Dec 31, 2025 | 12.34 Mn |
| Sep 30, 2025 | 18.80 Mn |
| Jun 30, 2025 | 17.44 Mn |
| Mar 31, 2025 | 34,155.00 |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 652,659.00 |
| Jun 30, 2024 | 31,308.00 |
| Mar 31, 2024 | 300,837.00 |
| Dec 31, 2023 | 66,128.00 |
| Sep 30, 2023 | 293,900.00 |
| Jun 30, 2023 | 205,836.00 |
| Mar 31, 2023 | 48,386.00 |
| Dec 31, 2022 | 407,131.00 |
| Sep 30, 2022 | 969,125.00 |
| Jun 30, 2022 | 2.04 Mn |
| Mar 31, 2022 | 3.34 Mn |
| Dec 31, 2021 | 239,144.00 |